Beetroot juice may boost walking distance in leg artery disease

NCT ID NCT05624125

Recruiting now Symptom relief Sponsor: Northwestern University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether drinking beetroot juice daily for 4 months can improve walking distance in people with peripheral artery disease (PAD). Researchers will compare a beetroot juice group to a placebo group in 210 adults aged 50 and older. The main goal is to see if beetroot juice increases how far participants can walk in 6 minutes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: beetroot juice
What this could lead to: If it works, this could offer a simple, natural way to improve walking ability in people with peripheral artery disease.
What could go wrong: This is a mid-sized trial testing a dietary supplement, not a drug. The effect may be small or not clinically meaningful, and results may not apply to everyone with PAD.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intermittent vascular claudication peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERY DISEASE

Contacts and locations

Locations

Northwestern University Feinberg School of Medicine
RECRUITING

Chicago, Illinois, 60611, United States
University of Chicago
RECRUITING

Chicago, Illinois, 60637, United States
University of Minnesota
RECRUITING

Minneapolis, Minnesota, 55455, United States
University of Virginia
ACTIVE_NOT_RECRUITING

Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.